Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
1
x
$
30.00
Gregory J. Moore, PhD: Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders
1
x
$
30.00
An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome
1
x
$
30.00
View Cart
Checkout
Home
Misdiagnosis of Catatonia (OPEN ACCESS)
“An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome” has been added to your cart.
View cart
Misdiagnosis of Catatonia (OPEN ACCESS)
$
0.00
Misdiagnosis of Catatonia (OPEN ACCESS) quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Open Access Articles
,
VOL 50 No. 1 Articles 2020
Tags:
Agastya Nayar
,
benzodiazepines
,
catatonia
,
feras-ali-mustafa
,
lorazepam challenge
,
memantine
,
misdiagnosis
Description
Description
Letter to the Editor
Misdiagnosis of Catatonia
By Feras Ali Mustafa, Agastya Nayar
Related products
Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
$
30.00
Add to cart
Details
Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain
$
30.00
Add to cart
Details
Catatonia and CPK Elevation in Neurosyphilis
$
30.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
Page load link
Go to Top